Est. EPS Q/Q of BioAmber Inc.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the next quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers primarily in the United States and Canada. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company's bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol and tetrahydrofuran used in elastomers, engineering plastics, shoe soles, spandex, and solvents; succinic acid based polyesters for use in automotive interiors, fibers and non-wovens, food packaging, plastic bags and cups, and organic composite boards; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine used in carpets, engineering plastics, textiles and fibers, films, and polyurethanes. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.
|CALA Calithera Biosciences, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$27.1M|
|PIRS Pieris Pharmaceuticals, Inc.||NASDAQ > Health Care > Biotechnology: Commercial Physical & Biological Resarch||-$27M|
|EKSO Ekso Bionics Holdings, Inc.||NASDAQ > Capital Goods > Industrial Machinery/Components||-$26.6M|
|LQDT Liquidity Services, Inc.||NASDAQ > Miscellaneous > Business Services||-$26.4M|
|AGLE Aeglea BioTherapeutics, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$26.4M|
|TLND Talend S.A.||NASDAQ > Technology > Computer Software: Prepackaged Software||-$26.3M|
|BIOA BioAmber Inc.||NYSE > Basic Industries > Major Chemicals||-$26.2M|
|CHL China Mobile (Hong Kong) Ltd.||NYSE > Public Utilities > Telecommunications Equipment||$42.5B|
|PTR PetroChina Company Limited||NYSE > Energy > Oil & Gas Production||$43.1B|
|VZ Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|VZA Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|T AT&T Inc.||NYSE > Public Utilities > Telecommunications Equipment||$48.2B|
|AAPL Apple Inc.||NASDAQ > Technology > Computer Manufacturing||$74.2B|